查詢結果分析
來源資料
相關文獻
- Glypican-3 Expression in Breast Cancer
- The Effects of Pesticides Chlordane, Dieldrin and Endosulfan on the Growth of Human Breast Cancer Cell Lines MCF-7 and SK-BR-3
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
- Cystic Hypersecretory Intraductal Carcinoma of the Breast--Case Report
- Timing of Shoulder Exercise after Modified Radical Mastectomy: A Prospective Study
- 前哨淋巴掃描診斷乳癌早期轉移
- Measurement of the Quality of Life during Different Clinical Phases of Breast Cancer
- The Prognostic Significance of Pathologic Characteristics of Breast Cancer Patients in Taiwan
- 趨勢面分析法在癌症地圖繪製上的應用: 以臺灣的乳癌死亡率為例
- 使用Tamoxifen治療乳癌
頁籤選單縮合
題 名 | Glypican-3 Expression in Breast Cancer=乳癌的Glypican-3之表現 |
---|---|
作 者 | 蔡青樺; 蘇煒迪; 沈陳石銘; 梁俊隆; 許世偉; 陳韋廷; 黃英彥; 黃昭誠; 饒坤銘; 唐瑞平; | 書刊名 | 臺灣癌症醫學雜誌 |
卷 期 | 2:4 2015.12[民104.12] |
頁 次 | 頁285-292 |
分類號 | 416.226 |
關鍵詞 | 乳癌; 組織微陣列; Glypican-3; Breast cancer; Tissue microarray; |
語 文 | 英文(English) |
中文摘要 | 前言:Glypican-3 已經在不同類型的腫瘤中被發現。然而,關於 Glypican-3 在乳癌的角色 的資訊仍然非常有限。組織微陣列使用對原始組織標本最小損害的平行原點塊來分析數 以千計的標本。本研究將使用組織微陣列檢測乳癌中的 Glypican-3 之表現。 材料方法:以組織微陣列的組織免疫染色來分析 99 個原發浸潤性乳腺癌案例的組織檢體 的 Glypican-3 之表現。結果將與臨床病理資料多元分析及比較。 結果:TNM 分期顯著與 5 年內的生存率相關。不過,Glypican-3 的表現與 5 年內的生存 率沒有明顯的關係。 結論:組織微陣列的組織免疫染色是方便及適合用於分析乳癌中的 Glypican-3。我們的初 步結果顯示,Glypican-3 的表現在乳腺癌無顯著預後價值。 |
英文摘要 | Background: The protein Glypican-3 has been found in various types of tumors and has shown promise as a tumor marker. However, there is still very limited information about the role of Glypican-3 in breast cancer. Tissue microarray (TMA) analyzes thousands of specimens in parallel with minimal damage to the origin blocks. The purpose of this study was to ascertain the role of Glypican-3 status in breast cancer using TMA. Materials and Methods: Archival tissue specimens from 99 patients with primary invasive breast cancer were analyzed for Glypican-3 expression by immunohistochemical staining with TMA. The results were compared to clinicopathologic data by the use of multivariate analysis. Results: TNM stage was significantly related to the overall 5-year survival rate. Nevertheless, Glypican-3 expression has no significant relationship to overall five-year survival. Conclusions: Immunohistochemical staining with TMA was convenient and feasible for analyzing Glypican-3 expression status in breast cancer. However, our preliminary results show that Glypican-3 expression had no significant prognostic value in breast cancer. |
本系統中英文摘要資訊取自各篇刊載內容。